Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels

被引:19
|
作者
Pischon, Tobias
Moehlig, Matthias
Hoffmann, Kurt
Spranger, Joachim
Weikert, Cornelia
Willich, Stefan N.
Pfeiffer, Andreas F. H.
Boeing, Heiner
机构
[1] German Inst Human Nutr DlfE, Dept Epidemiol, Potsdam Rehbruecke, D-14558 Nuthetal, Germany
[2] Charite, Med Ctr, Inst Social Med, Epidemiol & Hlth Econ, Berlin, Germany
[3] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany
[4] Charite Univ Med Ctr, Dept Endocrinol Diabet & Nutr, Berlin, Germany
关键词
competing risk; epidemiology; myocardial infarction; population attributable fraction; risk factors; stroke;
D O I
10.1007/s10654-007-9141-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
C-reactive protein (CRP) was proposed as a stronger predictor of cardiovascular events than low-density lipoprotein cholesterol (LDL-C); however, these associations may differ between myocardial infarction (MI) and stroke. We compared statistically the associations of CRP and LDL-C levels with risk of MI versus stroke and examined to what extent consideration of CRP or LDL-C increases the population attributable fractions (PAFs) of MI and stroke beyond traditional risk factors among 27,548 subjects from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study in a case-cohort design. Among subjects without prior MI or stroke, 156 developed MI and 132 stroke during 6.0 years of follow-up. In adjusted competing risk analyses CRP was positively related to MI and stroke (P difference between endpoints = 0.55), whereas LDL-C was related to MI but not stroke (P difference between endpoints = 0.003). The PAF for smoking, diabetes, and hypertension combined was 0.76 for MI, and 0.58 for stroke. With additional consideration of CRP the PAFs were 0.80 and 0.68, while with addition of LDL-C the PAFs were 0.88 and 0.55. We conclude that CRP is equally strongly related to risk of MI and stroke, whereas LDL-C is related to risk of MI but not stroke. Consideration of LDL-C beyond smoking, diabetes and hypertension may increase the PAF of MI slightly more than CRP. In contrast, consideration of CRP but not of LDL-C may increase the PAF of stroke beyond these factors.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 50 条
  • [41] Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein
    Siudut, Jakub
    Zabczyk, Michal
    Wolkow, Pawel
    Polak, Maciej
    Undas, Anetta
    Jawien, Jacek
    VASCULAR PHARMACOLOGY, 2022, 144
  • [42] Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children?
    Rybi-Szuminska, A.
    Wasilewska, A.
    Michaluk-Skutnik, J.
    Osipiuk-Remza, B.
    Filonowicz, R.
    Zajac, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 (04) : 775 - 780
  • [43] Binding of C-reactive protein to modified low-density-lipoprotein particles:: identification of cholesterol as a novel ligand for C-reactive protein
    Taskinen, S
    Kovanen, PT
    Jarva, H
    Meri, S
    Pentikäinen, MO
    BIOCHEMICAL JOURNAL, 2002, 367 : 403 - 412
  • [44] Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol
    Sniderman, Allan D.
    Islam, Shofiqul
    McQueen, Matthew
    Pencina, Michael
    Furberg, Curt D.
    Thanassoulis, George
    Yusuf, Salim
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10):
  • [45] Blood Microbiota Modification After Myocardial Infarction Depends Upon Low-Density Lipoprotein Cholesterol Levels
    Amar, Jacques
    Lelouvier, Benjamin
    Servant, Florence
    Lluch, Jerome
    Burcelin, Remy
    Bongard, Vanina
    Elbaz, Meyer
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (19):
  • [46] Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
    Glynn, Robert J.
    Koenig, Wolfgang
    Nordestgaard, Borge G.
    Shepherd, James
    Ridker, Paul M.
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (08) : 488 - U31
  • [47] The Association Between Low-Density Lipoprotein Cholesterol and the Risk of Hemorrhagic Stroke
    Sheth, Samip
    Lee, Paul
    Gomes, Edward
    Risman, Marjorie
    Rader, Daniel J.
    Jacoby, Douglas
    CIRCULATION, 2019, 140
  • [48] C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy
    Puri, Rishi
    Nissen, Steven E.
    Libby, Peter
    Shao, Mingyuan
    Ballantyne, Christie M.
    Barter, Phillip J.
    Chapman, M. John
    Erbel, Raimund
    Raichlen, Joel S.
    Uno, Kiyoko
    Kataoka, Yu
    Nicholls, Stephen J.
    CIRCULATION, 2013, 128 (22) : 2395 - 2403
  • [49] Coronary artery disease prognosis and C-reactive protein levels improve in proportion to percent lowering of low-density lipoprotein
    O'Keefe, James H., Jr.
    Cordain, Loren
    Jones, Philip G.
    Abuissa, Hussam
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (01): : 135 - 139
  • [50] Elevated Levels of Oxidized Low-Density Lipoprotein Correlate Positively with C-Reactive Protein in Patients with Acute Coronary Syndrome
    Zhang, Ya-chen
    Wei, Jing-jing
    Wang, Fei
    Chen, Man-tian
    Zhang, Mao-zhen
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2012, 62 (02) : 365 - 372